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In the current issue of the Journal of Critical Care, a retrospective study reports that patients 
intubated and ventilated in the emergency department (ED) are at high risk of acute respiratory 
distress syndrome (ARDS). This study included 182 eligible patients, from which 34 met the 
Berlin criteria (1) for ARDS within 48hrs of intubation.  The authors report that intubated 
patients in the ED had received initial tidal volumes (VT) of 1.5 ml/kg predicted body weight 
higher than the recommended standard of care of 4-6 ml/kg (2). The study later concluded that 
the majority of these patients had developed ARDS within 48 hours after intubation in the ED. 
Being a small, retrospective and descriptive study, the authors fail to investigate the clinical 
impact of such small increases in VT on ventilator adverse events or survival. It is well known 
from the ARDS NET trial, that VT greater than 10 ml/kg is not beneficial and harmful during 
ventilatory support of ARDS patients. The conclusion of the present study that small initial 
incremental increase in VT as low as 1 ml/kg can lead to worse outcomes or ventilator induced 
lung injury (VILI) or ARDS is highly debatable, and not supported by well-designed prospective 
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randomized trials. One should keep in mind that in the ARDS NET trial, the initial VT was 
8ml/kg and then reduced by 1ml/kg to goal VT of 6ml/kg. Despite the emphasis by the ARDS 
NET trial of keeping plateau pressures (PPlat) < 30cm H2O, the authors don’t describe what PPlat 
were used in their trial. In addition, the study does not account for preexisting confounding risk 
factors that can lead to ARDS. 
 In the ED setting, community acquired pneumonia, sepsis, trauma, and transfusion related lung 
injury (TRALI) are common etiologies of respiratory failure requiring ventilator support, that 
may ultimately lead to ARDS (3,4). Whereas in the intensive care unit, ventilator-associated 
pneumonia (VAP) should be considered (5,6). VAP is associated with increased mortality, 
morbidity and health costs (7), hence a tiered surveillance definition of ventilatory adverse 
events was recently described (8). Based on the task force recommendations, VAP is likely when 
respiratory deterioration was accompanied with fever, elevated white count, new antibiotic 
regimen, positive cultures and purulent secretions. The possibility of VAP was not accounted for, 
nor described in the reported study. Interestingly, the incidence of ARDS in the study coincided 
with the reported VAP incidence of 10-20% (9). Did these patients develop VAP? Did these 
patients have positive blood or sputum cultures? These important confounding variables should 
have been considered in the trial. Moreover, comorbid conditions that might have affected VT 
selection in the ED were not accounted for; for example, physicians might have chosen lower 
tidal volumes for patients with asthma or chronic obstructive pulmonary disease to avoid auto-
peep or higher tidal volumes for head trauma patients they wanted to hyperventilate. In addition, 
brain natriuretic peptide data and echocardiography were not available for cases that required 
intubation secondary to worsening cardiogenic pulmonary edema.  
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The authors’ concluded that the majority of patients intubated in the ED, subsequently developed 
ARDS because they had tidal volume settings 80 mL higher (1.5 mL/kg) than the recommended 
6 mL/kg of PBW. This conclusion is based on low quality evidence due to the study’s low 
power, unaccounted confounding variables and pre-existing risk factors. A myriad of potential 
co-morbidities may have caused ARDS in these patients. A sole comparison of VT settings and 
not considering patients’ history, co-morbidities, or the indication for intubation, questions the 
strong conclusion of this manuscript. In our opinion, the scientific evidence for appropriate 
ventilation in the ED remains unknown. Lung protective strategies should be implemented as 
soon as ventilator support is initiated while taking into account the patient’s clinical presentation 
and co-morbidities. Future, well designed, studies are needed to elucidate which ventilation 
strategy is optimal in ED patients suffering from neuro trauma, heart failure or asthma. 
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